Life, 2023 · DOI: 10.3390/life13010009 · Published: December 20, 2022
Traumatic spinal cord injury (SCI) leads to physical and psychological issues through complex pathological processes. SCI involves primary mechanical damage and secondary injury which includes vascular disruption, inflammation and glial scar formation. These events prevent nerve regeneration. Neurotrophic and growth factors, and cytokines are involved in the nervous system, and the blood-spinal cord barrier (BSCB) is damaged allowing immune cells to infiltrate. After a spinal cord injury, the microenvironment changes with various blood vessels and neurons. During the acute phase, microvasculature destruction results in cell degeneration/necrosis, and inflammatory cells release many cytokines into the injury site, which then causes ionic imbalance, excitotoxicity, calcium influx and free-radical production. The subacute phase involves astrocytes, microglia and NG2 cells stimulated by cytokines to proliferate and migrate to the lesion. Blood vessels that have ruptured or are dysfunctional (i.e., leaking) have major roles in the progressive nature of tissue loss and the inability of nerve tissue to heal in the spinal cord. Ruptured blood vessels cause hemorrhages, which accelerate tissue loss. Though angiogenesis occurs at the injury site, it doesn’t provide enough vascularization, inhibiting the body’s natural healing process.
Modulating the expression or activity of neurotrophic factors like NGF and BDNF may improve neuronal survival and axonal regeneration following SCI.
Strategies to regulate vascular responses, such as promoting angiogenesis and maintaining BSCB integrity, are essential for improving outcomes after SCI.
Targeting specific cytokines to balance the inflammatory response may reduce secondary damage and promote tissue repair in SCI.